How it started
History
BioGaia was founded in 1990 to develop and commercialize a new strain of L. reuteri. The company's research director Dr. Ivan Casas believed that newborn chickens consumed their mothers' feces, allowing the transfer of beneficial microorganisms from the mother to the sterile newborn bird. He believed that the same was true for humans. It is generally accepted that newborn babies are sterile at birth and are very sensitive to pathogenic bacteria before they establish a microbial flora of their own.
This flora should preferably come from their mother. Ivan believed that Lactobacillus reuteri is one of the bacteria that a mother should transfer to her offspring, whether a chicken, a human baby or any other mammal. He wanted to create probiotic products that would confirm this "Circle of Life”.
The first step involved analysis of breast milk from mothers in the United States, Sweden, Israel, South Africa, Denmark, Japan, Peru and South Korea. Approximately 14–15% of the samples contained L. reuteri. In a separate study, Casas found that samples of breast milk collected from women in Andean villages in Peru also contained numerous strains of L. reuteri, which were subsequently isolated.
One of these strains is still used in BioGaia’s probiotic products.
From Wikipedia’s article on BioGaia, shared under CC BY-SA 4.0.2